Indegene Ltd (INDGN) - Net Assets

Latest as of March 2026: Rs31.39 Billion INR ≈ $339.44 Million USD

Based on the latest financial reports, Indegene Ltd (INDGN) has net assets worth Rs31.39 Billion INR (≈ $339.44 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs46.20 Billion ≈ $499.67 Million USD) and total liabilities (Rs14.82 Billion ≈ $160.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Indegene Ltd balance sheet quality to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets Rs31.39 Billion
% of Total Assets 67.93%
Annual Growth Rate N/A
5-Year Change 310.88%
10-Year Change N/A
Growth Volatility 40.05

Indegene Ltd - Net Assets Trend (2020–2026)

This chart illustrates how Indegene Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see INDGN market cap overview.

Annual Net Assets for Indegene Ltd (2020–2026)

The table below shows the annual net assets of Indegene Ltd from 2020 to 2026. Also explore INDGN net asset momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2026-03-31 Rs31.39 Billion
≈ $339.44 Million
+20.00%
2025-03-31 Rs26.16 Billion
≈ $282.87 Million
+83.02%
2024-03-31 Rs14.29 Billion
≈ $154.55 Million
+34.35%
2023-03-31 Rs10.64 Billion
≈ $115.04 Million
+39.25%
2022-03-31 Rs7.64 Billion
≈ $82.61 Million
+129.34%
2021-03-31 Rs3.33 Billion
≈ $36.02 Million
+2235.45%
2020-03-31 Rs-155.98 Million
≈ $-1.69 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Indegene Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 135523000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2026)

Component Amount Percentage
Common Stock Rs481.00 Million 1.53%
Other Components Rs30.91 Billion 98.47%
Total Equity Rs31.39 Billion 100.00%

Indegene Ltd Competitors by Market Cap

The table below lists competitors of Indegene Ltd ranked by their market capitalization.

Company Market Cap
Top Glove Corporation Bhd
KLSE:7113
$1.56 Billion
Kemper Corporation
NYSE:KMPR
$1.56 Billion
SL Corp
KO:005850
$1.56 Billion
Permian Basin Royalty Trust
NYSE:PBT
$1.56 Billion
Emlak Konut Gayrimenkul Yatirim Ortakligi AS
IS:EKGYO
$1.56 Billion
Central Securities Corporation
NYSE MKT:CET
$1.56 Billion
General American Investors Closed Fund
NYSE:GAM
$1.56 Billion
DUERR AG UNSP.ADR 1/5
F:DUEB
$1.56 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Indegene Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 26,156,000,000 to 31,387,000,000, a change of 5,231,000,000 (20.0%).
  • Net income of 4,011,000,000 contributed positively to equity growth.
  • Dividend payments of 480,000,000 reduced retained earnings.
  • New share issuances of 53,000,000 increased equity.
  • Other comprehensive income decreased equity by 972,000,000.
  • Other factors increased equity by 2,619,000,000.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income Rs4.01 Billion +12.78%
Dividends Paid Rs480.00 Million -1.53%
Share Issuances Rs53.00 Million +0.17%
Other Comprehensive Income Rs-972.00 Million -3.1%
Other Changes Rs2.62 Billion +8.34%
Total Change Rs- 20.00%

Book Value vs Market Value Analysis

This analysis compares Indegene Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.61x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-03-31 Rs-5.30 Rs600.10 x
2021-03-31 Rs13.56 Rs600.10 x
2022-03-31 Rs31.93 Rs600.10 x
2023-03-31 Rs44.46 Rs600.10 x
2024-03-31 Rs59.82 Rs600.10 x
2025-03-31 Rs109.46 Rs600.10 x
2026-03-31 Rs130.06 Rs600.10 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Indegene Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.78%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.43%
  • • Asset Turnover: 0.76x
  • • Equity Multiplier: 1.47x
  • Recent ROE (12.78%) is below the historical average (20.64%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 0.00% 8.67% 1.07x 0.00x Rs662.76 Million
2021 46.04% 15.46% 1.62x 1.84x Rs1.17 Billion
2022 21.57% 9.90% 1.23x 1.77x Rs883.72 Million
2023 25.02% 11.54% 1.05x 2.07x Rs1.60 Billion
2024 23.56% 13.00% 1.02x 1.78x Rs1.94 Billion
2025 15.55% 14.32% 0.85x 1.27x Rs1.45 Billion
2026 12.78% 11.43% 0.76x 1.47x Rs872.30 Million

Industry Comparison

This section compares Indegene Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $51,530,830,000
  • Average return on equity (ROE) among peers: 22.79%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Indegene Ltd (INDGN) Rs31.39 Billion 0.00% 0.47x $1.56 Billion
INVENTURUS KNOWLEDGE SO L (IKS) $6.47 Billion 36.00% 0.22x $3.23 Billion
SAGILITY INDIA LIMITED (SAGILITY) $96.59 Billion 9.57% 0.30x $2.31 Billion

About Indegene Ltd

NSE:INDGN India Health Information Services
Market Cap
$1.56 Billion
Rs144.21 Billion INR
Market Cap Rank
#7127 Global
#346 in India
Share Price
Rs600.10
Change (1 day)
+1.41%
52-Week Range
Rs423.50 - Rs611.65
All Time High
Rs732.70
About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more